Clinical Trial Update: A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating amycretin tablets in Japanese men with obesity has completed. The trial aimed to assess safety and pharmacokinetics in this populatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Amycretin

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED